Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Ravaud

Showing results (111-120 of 221) with videos related to

Pageof 23
Sort By:
Urology|October 30, 2009
Therapeutic management of de novo urological malignancy in renal transplant recipients: the experience of the French Department of Urology and Kidney Transplantation from BordeauxHicham Elkentaoui, Grégoire Robert, Gilles Pasticier, et al.
Bulletin Du Cancer|October 9, 2014
[Alternative prescription schedules of sunitinib in metastatic kidney cancer: from the underground to the light?]Antoine Thiery-Vuillemin, Guillaume Mouillet, Damien Pouessel, et al.
Cancer Treatment Reviews|August 18, 2020
Current management and future perspectives of penile cancer: An updated reviewFlorent Peyraud, Clément Allenet, Marine Gross-Goupil, et al.
Bulletin Du Cancer|April 2, 2020
[SARS-CoV-2/COVID 19 Infection and Solid Cancers: Synthesis of Recommendations for Health Professionals]Thomas Grellety, Alain Ravaud, Anne Canivet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2008
Efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe renal cell carcinomaToni K Choueiri, Anne Plantade, Paul Elson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
Randomized study of intravenous versus subcutaneous interleukin-2, and IFNalpha in patients with good prognosis metastatic renal cancerSylvie Négrier, David Perol, Alain Ravaud, et al.
The Lancet. Oncology|March 30, 2020
The official French guidelines to protect patients with cancer against SARS-CoV-2 infectionBenoit You, Alain Ravaud, Anne Canivet, et al.
Pharmacology Research & Perspectives|June 23, 2020
A multicenter, phase I, pharmacokinetic study of osimertinib in cancer patients with normal renal function or severe renal impairmentKarthick Vishwanathan, Inmaculada Sanchez-Simon, Bhumsuk Keam, et al.
Cancers|December 9, 2023
Clinical and Biological Differences between Upper Tract Carcinoma and Bladder Urothelial Cancer, Including Implications for Clinical PracticeFélix Lefort, Yasmine Rhanine, Mathieu Larroquette, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2020
Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor of Disease-free Survival in Postnephrectomy High-risk Locoregional Renal Cell Carcinoma: Analysis of the S-TRAC TrialAnup Patel, Alain Ravaud, Robert J Motzer, et al.
Pageof 23

Showing results (111-120 of 221) with videos related to

Sort By:
Pageof 23
Urology|October 30, 2009
Therapeutic management of de novo urological malignancy in renal transplant recipients: the experience of the French Department of Urology and Kidney Transplantation from BordeauxHicham Elkentaoui, Grégoire Robert, Gilles Pasticier, et al.
Bulletin Du Cancer|October 9, 2014
[Alternative prescription schedules of sunitinib in metastatic kidney cancer: from the underground to the light?]Antoine Thiery-Vuillemin, Guillaume Mouillet, Damien Pouessel, et al.
Cancer Treatment Reviews|August 18, 2020
Current management and future perspectives of penile cancer: An updated reviewFlorent Peyraud, Clément Allenet, Marine Gross-Goupil, et al.
Bulletin Du Cancer|April 2, 2020
[SARS-CoV-2/COVID 19 Infection and Solid Cancers: Synthesis of Recommendations for Health Professionals]Thomas Grellety, Alain Ravaud, Anne Canivet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2008
Efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe renal cell carcinomaToni K Choueiri, Anne Plantade, Paul Elson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
Randomized study of intravenous versus subcutaneous interleukin-2, and IFNalpha in patients with good prognosis metastatic renal cancerSylvie Négrier, David Perol, Alain Ravaud, et al.
The Lancet. Oncology|March 30, 2020
The official French guidelines to protect patients with cancer against SARS-CoV-2 infectionBenoit You, Alain Ravaud, Anne Canivet, et al.
Pharmacology Research & Perspectives|June 23, 2020
A multicenter, phase I, pharmacokinetic study of osimertinib in cancer patients with normal renal function or severe renal impairmentKarthick Vishwanathan, Inmaculada Sanchez-Simon, Bhumsuk Keam, et al.
Cancers|December 9, 2023
Clinical and Biological Differences between Upper Tract Carcinoma and Bladder Urothelial Cancer, Including Implications for Clinical PracticeFélix Lefort, Yasmine Rhanine, Mathieu Larroquette, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2020
Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor of Disease-free Survival in Postnephrectomy High-risk Locoregional Renal Cell Carcinoma: Analysis of the S-TRAC TrialAnup Patel, Alain Ravaud, Robert J Motzer, et al.
Pageof 23